Status:
TERMINATED
Accuracy of Non-invasive Continuous CO2-Monitoring
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
SenTec AG, Ringstrasse 39, CH-4106 Therwil
Conditions:
Blood Gas Monitoring, Transcutaneous
Eligibility:
All Genders
18+ years
Brief Summary
Arterial carbon dioxide partial pressure (PaCO2) is an essential indicator of ventilation and respiratory function. It is routinely tested invasively by arterial blood gas analysis (ABGA) but recently...
Detailed Description
Measurement of SO2 is used in nearly every patient receiving anesthesia or sedation, whereas monitoring of pCO2 is important in patients during and shortly after major surgery and in critically ill pa...
Eligibility Criteria
Inclusion
- Patients older than 18 years with clinical indication of repeated arterial blood gas analyses
Exclusion
- No informed consent
Key Trial Info
Start Date :
July 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00247949
Start Date
July 1 2004
End Date
February 1 2006
Last Update
November 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Basel, CH, Switzerland, 4031